What is the appropriate management for a child who develops a rash after receiving a normal saline (0.9% sodium chloride) infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Rash After Normal Saline in Children

Stop the infusion immediately, maintain IV access, assess for signs of anaphylaxis, and if present, administer intramuscular epinephrine 0.01 mg/kg (maximum 0.5 mg) into the lateral thigh while simultaneously calling for medical assistance.

Immediate Assessment and Action

When a child develops a rash during or after normal saline infusion, you must rapidly determine whether this represents a true hypersensitivity reaction or anaphylaxis versus a benign infusion reaction. The distinction is critical for morbidity and mortality outcomes.

First Steps (Within Seconds)

  • Stop the infusion but maintain IV access 1
  • Assess ABCs (Airway, Breathing, Circulation) and level of consciousness 1
  • Position the child appropriately: Trendelenburg if hypotensive, sitting up if respiratory distress, recovery position if unconscious 1
  • Call for medical assistance immediately 1

Determine Severity: Is This Anaphylaxis?

Anaphylaxis is present if the child meets ANY of these criteria:

  1. Acute onset with skin/mucosal involvement (rash, urticaria, angioedema) PLUS respiratory compromise OR hypotension
  2. Two or more systems involved rapidly after exposure (skin, respiratory, cardiovascular, GI)
  3. Hypotension after known allergen exposure

Key vital sign thresholds for hypotension in children 2:

  • Term neonates (0-28 days): <60 mmHg systolic
  • Infants (1-12 months): <70 mmHg systolic
  • Children (>1 year to 10 years): <70 + (2 × age in years) mmHg systolic
  • Beyond 10 years: <90 mmHg systolic

Treatment Algorithm

If Anaphylaxis is Suspected (Life-Threatening)

Epinephrine is the first-line, life-saving intervention 1, 3:

  • Dose: 0.01 mg/kg of 1:1000 solution (maximum 0.3-0.5 mg) 3
  • Route: Intramuscular into lateral thigh (preferred route) 3
  • Repeat: Every 5-15 minutes as needed 1
  • If no response: Consider IV epinephrine infusion 0.1-1.0 μg/kg/min 3

Fluid resuscitation 1:

  • Rapid infusion of normal saline at 5-10 mL/kg in first 5 minutes
  • Crystalloids in boluses of 20 mL/kg, followed by slow infusion
  • Children may require up to 30 mL/kg in the first hour 2

Antihistamines (adjunctive, NOT first-line) 1:

  • Diphenhydramine 1-2 mg/kg IV (maximum 50 mg) PLUS
  • Ranitidine 50 mg IV (diluted, given over 5 minutes)
  • Combined H1/H2 blockade is superior to either alone 1

Corticosteroids 1:

  • Methylprednisolone 1-2 mg/kg IV every 6 hours
  • Prevents biphasic reactions but NOT critical for acute management
  • Do not delay epinephrine to give steroids

If refractory hypotension 1:

  • Dopamine 2-20 μg/kg/min titrated to blood pressure 3, 2
  • Vasopressin 0.01-0.04 U/min may be considered if unresponsive to epinephrine 1

If Mild Hypersensitivity Reaction (Non-Life-Threatening)

For isolated rash without systemic symptoms:

  • Slow or temporarily stop the infusion 1
  • Administer antihistamines: Diphenhydramine 1-2 mg/kg IV plus ranitidine 1
  • Consider corticosteroids: Methylprednisolone 1-2 mg/kg IV 1
  • Monitor vital signs continuously
  • May restart infusion at 50% rate after symptom resolution, titrating to tolerance 1

Post-Reaction Management

  • Monitor vital signs until complete resolution 1
  • 24-hour observation recommended for severe reactions 1
  • Document thoroughly: pre-infusion assessment, reaction description, grading, and management 1
  • Do NOT rechallenge if the reaction was severe (Grade 3/4) or true anaphylaxis 1

Critical Pitfalls to Avoid

Common mistakes that increase morbidity:

  1. Delaying epinephrine: Antihistamines and steroids are NOT substitutes for epinephrine in anaphylaxis. Epinephrine must be given immediately when anaphylaxis criteria are met 1, 3.

  2. Wrong epinephrine concentration: Use 1:1000 (1 mg/mL) for IM injection, NOT 1:10,000 which is for IV use 3. Double-check the concentration before drawing up.

  3. Wrong route: IM into lateral thigh is preferred over subcutaneous for anaphylaxis 3. IV epinephrine requires careful titration and monitoring.

  4. Inadequate fluid resuscitation: Children in anaphylactic shock often require large volumes (20-30 mL/kg) 1, 2. Don't be timid with fluids.

  5. Assuming it's "just a rash": Normal saline itself rarely causes true allergic reactions, but contaminants, additives, or concurrent medications can. However, true hypersensitivity reactions to normal saline components have been reported in the literature, though they remain uncommon 4.

Special Considerations

True allergy to normal saline is extremely rare 4. More commonly, rashes during saline infusion result from:

  • Concurrent medications or additives
  • Rapid infusion rate causing histamine release
  • Underlying conditions (e.g., mastocytosis)
  • Contamination or incompatibility issues

For patients on beta-blockers (rare in children but important): Glucagon 1-5 mg IV over 5 minutes may be needed for refractory cardiovascular effects 1.

Equipment must be ready: Before any infusion, ensure resuscitation equipment including epinephrine, oxygen, and airway management tools are immediately available 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.